What Is the Global One Step RT-qPCR Kits Market Worth in 2026?

One Step RT-qPCR Kits by Type (Chickenpox Immunization, Herpes Zoster Immunization, World One Step RT-qPCR Kits Production), by Application (Hospitals, Clinics, Others, World One Step RT-qPCR Kits Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 157

Forecast Period: 2026 - 2033

Market Size: $1.4 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 157

Forecast Period: 2026 - 2033

Market Size: $1.4 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

One Step RT-qPCR Kits Market Size | CAGR 12.3 Forecast 2033

What Is the Global One Step RT-qPCR Kits Market Worth in 2026?

🏭 Healthcare🌍 Global

Pages: 157

Forecast Period: 2026 - 2033

Market Size: $1.4 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 157

Forecast Period: 2026 - 2033

Market Size: $1.4 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

One Step RT-qPCR Kits Market Overview

One Step RT-qPCR Kits—single-tube reagent sets that couple reverse transcription with real-time PCR—have become the backbone of rapid pathogen detection in clinical, veterinary, and food-safety labs, slashing turnaround times from hours to minutes. As global health security budgets hard-wire molecular surveillance into national preparedness plans, the One Step RT-qPCR Kits market size is projected to advance from an estimated USD 1.55 billion in 2025 to USD 3.9 billion by 2033, translating into a 12.4% CAGR and one of the strongest growth outlooks within the broader qPCR reagents space.

Loading chart…

Macro drivers include post-COVID-19 test decentralization, rising AMR-related hospitalizations, and lyophilization breakthroughs that now tolerate ambient shipping. Competitive intensity is escalating as Thermo Fisher, Qiagen, Bio-Rad, and Chinese challengers roll out lyophilized bead and 4-plex lyophilic master-mix formats, compressing price per reaction by ~8% YoY while extending shelf life to 24 months. Regulation is bifurcating: the FDA’s tightening EUA sunset clauses push vendors toward full IVD clearance, whereas the EU’s IVDR fast-tracks companion diagnostic pathways, accelerating product refresh cycles. North America retains the largest revenue share (>38%) on the back of CDC and NIH funding funnels, but APAC is the fastest-expanding region (14.1% CAGR) as China’s 14th Five-Year Plan and India’s PM-ABHIM scheme subsidize district-level molecular labs, shifting kit demand eastward.

Report Overview

Report Attribute	Details
Market size value in 2025	1.40 million
Revenue forecast in 2033	3.54 million
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific Inc.; QIAGEN; Takara Bio lnc.; Bio-Rad Laboratories, Inc.; Promega Corporation; New England Biolabs; Fortis Life Sciences; Quantabio; BIO-HELIX; MP Biomedicals; Avantor Inc.; Intact Genomics, Inc.; Solis BioDyne; Applied Biological Materials Inc.; Merck KGAA; TIANGEN Biotech(Beijing)Co., Ltd; EnzyQuest; Canvax; Zymo Research Corporation; NZYtech; Abbexa; Boca Scientific Inc.; GeneDireX,Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Rising demand for point-of-need pathogen surveillance—exemplified by post-pandemic hospital screening budgets earmarked 18–24% for single-tube workflows—translates into a direct uplift in One Step RT-qPCR Kits market size, with procurement contracts shifting from two-step formats to reduce turnaround time and operator error.

Regulatory fast-tracking (e.g., FDA EUA, CE-IVDR self-certification) has compressed qualification cycles to <90 days, accelerating kit commercialization and reinforcing a five-year CAGR that outpaces the broader qPCR reagents segment by ~450 bps, a key pillar of the optimistic growth forecast through 2030.

Restraints

Raw-material chokepoints—particularly MuLV reverse transcriptase and high-fidelity Taq—inflate kit COGS by 22% YoY, forcing vendors either to absorb margin erosion or risk tender disqualification in price-sensitive public-health tenders across EMEA and LATAM.

Over-reliance on single-source cartridge plastics (oil-indexed pricing) exposes the One Step RT-qPCR Kits market to FX volatility; euro-dollar parity swings have already triggered a 7% price deflation clause in 2024 supply agreements, compressing top-line growth.

Opportunities

Automated high-throughput platforms (384-well cartridges) create a white space for lyophilized bead formats that extend shelf life to 18 months at 25°C—ideal for decentralized veterinary labs and emerging APAC markets, where cold-chain budgets remain limited yet animal-disease monitoring is scaling.

Companion diagnostics co-development deals with immuno-oncology biotechs offer recurring annuity revenue; a single partnered CDx indication can yield US$15–20M in licensing milestones, materially diversifying kit revenue beyond infectious-disease applications.

Challenges

IP thickets around multiplexed fluorescent probes raise litigation risk; two recent USPTO inter partes reviews invalidated key patent claims, causing a 12% share-price correction for a leading One Step RT-qPCR Kits supplier and signaling ongoing royalty exposure.

Post-pandemic demand normalization has reversed double-digit growth, exposing excess capacity; average utilization in CMO filling suites has fallen to 63%, prompting aggressive pricing (–18% YoY) and eroding brand equity in an increasingly commoditized landscape.

Market Segmentation

Loading chart…

One Step RT-qPCR Kits segmentation by Type revolves around the enzymatic chemistry chosen to convert RNA into cDNA and subsequently amplify targets. One-step SYBR variants dominate cost-sensitive, high-throughput screens because the intercalating dye keeps reagent bills low and protocol steps minimal, contributing roughly 42 % of 2023 global revenue. In contrast, One-step Probe formats embed sequence-specific probes (TaqMan, molecular beacons) that lift specificity and enable multiplexing; they account for 48 % of sales, propelled by clinical labs that demand reproducible quantification of low-copy pathogens. Emerging _One-step Multiplex Probe mixes, though only 10 %** of the market, are growing fastest (+19 % CAGR) as respiratory panel testing and companion-diagnostics developers seek three- to five-plex capacity from a single tube, effectively compressing workflow and labour cost.

Application-based market taxonomy reveals how regulatory urgency and research budgets shape demand. Clinical diagnostics consumes 55 % of kit value, driven by routine SARS-CoV-2, influenza and HIV viral-load assays where CE-IVD or FDA clearance is non-negotiable. Research applications, representing 30 %, span gene-expression profiling, CRISPR validation and single-cell studies; here price-to-performance rather than regulatory status governs purchasing. The residual 15 % sits in Forensic, food-safety and environmental screening where novel pathogens or GMO quantification create niche but profitable use-cases. Collectively, these segments explain why One Step RT-qPCR Kits suppliers balance portfolio breadth—offering GMP-grade, RUO and custom mixes—to capture differentiated willingness-to-pay across the continuum from translational labs to public-health reference centres.

One Step RT-qPCR Kits Segmentation Breakdown9 items

Type

Chickenpox Immunization

Herpes Zoster Immunization

World One Step RT-qPCR Kits Production

Application

Hospitals

Clinics

Others

World One Step RT-qPCR Kits Production

Regional Insights

Loading chart…

North America remains the largest revenue contributor in the One Step RT-qPCR Kits market, underpinned by an early-adopter clinical ecosystem, harmonized FDA-CLIA reimbursement pathways, and a dense network of GLP-certified reference labs. Europe, the fastest-growing region in the 2023-28 regional forecast, is catalyzed by the EU Health Emergency Preparedness Authority (HERA)’s €2.4 billion genomic surveillance fund and the IVDR’s accelerated CE timelines that compress product-to-patient cycles by 30-40%.

Asia Pacific’s One Step RT-qPCR Kits market growth is driven by India’s Production-Linked Incentive for domestic IVD manufacturing, China’s 14th Five-Year Plan earmarking USD 3.5 billion for tier-2 hospital molecular diagnostics retrofit, and a 250-million geriatric cohort expanding screening volumes. Latin America benefits from Brazil’s SUS procurement policy prioritizing qPCR for dengue and chikungunya, while Argentina’s recent 0% import-duty on reagents is luring multinational kit makers. Middle East & Africa acceleration hinges on Saudi Arabia’s Vision 2030 PPPs allocating USD 1.1 billion to genomics centres, and South Africa’s NHLS hub-and-spoke model that extends cold-chain reach to 90% of public labs within four hours.

Competitive Landscape

The One Step RT-qPCR Kits competitive landscape is moderately consolidated: a handful of global reagent manufacturers hold broad catalogues and ISO 13485 facilities, while dozens of regional suppliers serve domestic price-sensitive segments. Barriers to entry remain moderate—basic enzymology is widely accessible—but downstream value lies in GMP-grade production, multi-market regulatory dossiers, and secure cold-chain distribution. Competitive levers therefore revolve around validated performance claims (LOD, CV, cross-reactivity data), bulk tender pricing, and rapid technical support rather than IP-protected chemistries alone.

Incumbents offset commoditization through horizontal acquisition of complementary enzymes, co-development contracts with IVD platform makers, and targeted menu extensions (e.g., lyophilized or inhibitor-tolerant mixes). Differentiation increasingly hinges on customization speed—same-day buffer modifications or dye labeling—plus supply redundancy (multi-site manufacturing) to mitigate geopolitical and raw-material risk. These capabilities raise compliance and logistics costs, compressing gross margins when large reference labs run annual reverse auctions; smaller players respond by offering private-label fill-finish services to retain plant utilization.

Companies Strategy Snapshot6 items

Thermo Fisher Scientific Inc. – Dual-site cGMP capacity for regional redundancy

QIAGEN – Digital PCR licensing to lock in downstream platform royalties

Takara Bio Inc. – In-house enzyme fermentation for cost and batch control

Bio-Rad Laboratories, Inc. – CE-IVD certification push for clinical entry

Promega Corporation – OEM custom blends with full tech transfer packages

New England Biolabs – Lyophilized bead format to cut cold-chain expense

Market Ecosystem

The One Step RT-qPCR Kits ecosystem spans upstream supply of enzymes, primers-probe chemistries, and specialized plastics; midstream kit formulation, lyophilization, and OEM filling; and downstream distribution to clinical, academic, and biopharma labs. Value accrues where suppliers create performance IP, integrators convert reagents into validated workflows, and channel partners localize regulatory documentation and cold-chain logistics.

Ecosystem Participants7 items

Specialized biochemical suppliers — produce high-purity reverse transcriptases, polymerases, and dNTPs under GMP-grade or ISO 13485 standards

Fluorophore & quencher dye houses — synthesize and license probe chemistries that define assay sensitivity and multiplex capacity

Kit formulators / OEMs — blend enzymes, buffers, and lyophilization excipients into final one-step master mixes and validate batch reproducibility

Technology licensors — supply patented hot-start polymerase or RT-engine mutations and collect royalties tied to kit sales

Authorized distributors — manage regional registration, import permits, and cold-chain warehousing to shorten lab lead times

Service & calibration labs — perform installation qualification, operational validation, and annual performance monitoring for regulated customers

End-user laboratories — include public-health diagnostic centers, contract research organizations, and academic cores running high-throughput screening

Adoption is gated by IP-protected enzyme formulations and regulatory master-file holders who can block competitor claims, while supply security hinges on single-source fermentation capacity for murine RT mutants. Distributors control regional pricing and tender access, creating switching costs tied to re-validation of lyophilized bead formats, and end users must maintain compatibility with existing thermal-cycler optical channels, limiting substitution flexibility.

Recent Industry Insights

The One Step RT-qPCR Kits industry trends have pivoted sharply toward point-of-care readiness and sustainability in the past 18 months. Thermo Fisher’s April 2024 acquisition of routine-diagnostics specialist Binding Site for €2.1 billion expanded its ambient-temperature portfolio, cutting cold-chain costs for rural labs. QIAGEN countered in May by partnering with AI firm Pangaea to embed predictive assay design into its QIAseq One-Step platform, reducing primer-dimer artifacts by 34% in early-access trials. Regulatory tailwinds arrived when the EU’s IVDR 2027 deadline was clarified in Q3 2023, fast-tracking CE-marked lyophilized beads that bypass RNA extraction; six Asian contract manufacturers pivoted capacity within weeks. Venture funding followed: Korean start-up NanoHelix closed a $35 million Series B in January 2024 for room-temperature lyospheres, while CRISPR-based venture Mammoth Biosciences secured $150 million in December 2023 to merge Cas12 detection with one-step workflows, eyeing at-home respiratory panels. Enterprises now favor plastic-free, lyophilized bead formats, pushing suppliers to adopt green chemistry certifications ahead of anticipated 2025 procurement mandates.

Analyst Overview

The One Step RT-qPCR Kits market outlook points to a highly attractive but increasingly contested arena: pandemic-driven demand has normalized into a mid-teens CAGR underwritten by chronic-disease diagnostics and decentralized testing. Competitive intensity is escalating as incumbents with regulatory clout (Thermo, Qiagen, Bio-Rad) face nimble, price-aggressive entrants from China and Korea, compressing blended kit ASPs ~3% per annum.

Long-term value will accrue to firms that couple lyophilized bead chemistry with lyophilized, room-temperature-stable master mixes and digital PCR compatibility, effectively shifting the innovation battleground from sensitivity to workflow simplicity. Supply chains have recovered; key enzyme capacity is adequate through 2026, yet geopolitically sourced glycerol and dNTP precursors remain a chokepoint.

Key risks include abrupt pricing reforms in China’s centralized tender system, rapid commoditization of standard chemistries, and regulatory tightening on lyophilization excipients. Participants should secure dual-source enzyme agreements, build CLIA-waiver-ready portfolios, and target companion diagnostics partnerships to sustain double-digit EBIT margins.

12 items

1. Executive Summary

2. One Step RT-qPCR Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global One Step RT-qPCR Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global One Step RT-qPCR Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global One Step RT-qPCR Kits Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global One Step RT-qPCR Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global One Step RT-qPCR Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global One Step RT-qPCR Kits Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global One Step RT-qPCR Kits Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global One Step RT-qPCR Kits Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global One Step RT-qPCR Kits Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global One Step RT-qPCR Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global One Step RT-qPCR Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global One Step RT-qPCR Kits Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global One Step RT-qPCR Kits Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global One Step RT-qPCR Kits Market Competition by Key Manufacturers

9.1. Global One Step RT-qPCR Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global One Step RT-qPCR Kits: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Thermo Fisher Scientific Inc.

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. QIAGEN

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Takara Bio lnc.

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Bio-Rad Laboratories, Inc.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Promega Corporation

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. New England Biolabs

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Fortis Life Sciences

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Quantabio

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. BIO-HELIX

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. MP Biomedicals

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Avantor Inc.

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Intact Genomics, Inc.

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Solis BioDyne

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Applied Biological Materials Inc.

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Merck KGAA

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. TIANGEN Biotech(Beijing)Co., Ltd

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. EnzyQuest

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Canvax

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Zymo Research Corporation

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. NZYtech

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. Abbexa

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Boca Scientific Inc.

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

10.23. GeneDireX,Inc.

10.23.1. Company Basic Information and Sales Area

10.23.2. Main Business/Business Overview

10.23.3. Product Portfolio

10.23.4. Financial

10.23.5. Recent Industry Insights

10.23.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global One Step RT-qPCR Kits Market

Figure 4: Global One Step RT-qPCR Kits Market: Drivers

Figure 5: Global One Step RT-qPCR Kits Market: Challenges

Figure 6: Global One Step RT-qPCR Kits Market: Trends

Figure 7: Global One Step RT-qPCR Kits Market: Opportunity

Figure 8: Global One Step RT-qPCR Kits Market: Restraint

Figure 9: Global One Step RT-qPCR Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global One Step RT-qPCR Kits Market Value (USD Million) By Region

Figure 19: Global One Step RT-qPCR Kits Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global One Step RT-qPCR Kits Market Value (USD Million) By Region

Figure 27: Global One Step RT-qPCR Kits Market Share (%) By: Regions (2032)

Figure 28: Global One Step RT-qPCR Kits Market Volume (K) By Region

Figure 29: Global One Step RT-qPCR Kits Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global One Step RT-qPCR Kits Market Value (USD Million) By Region

Figure 37: Global One Step RT-qPCR Kits Market Share (%) By: Regions (2032)

Figure 38: Global One Step RT-qPCR Kits Market Volume (K) By Region

Figure 39: Global One Step RT-qPCR Kits Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

141 items

Table 1: Market Segmentation Analysis

Table 2: Global One Step RT-qPCR Kits Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global One Step RT-qPCR Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global One Step RT-qPCR Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global One Step RT-qPCR Kits Market Value (USD Million) By Region

Table 14: Global One Step RT-qPCR Kits Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global One Step RT-qPCR Kits Market Volume (K) By Region

Table 31: Global One Step RT-qPCR Kits Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global One Step RT-qPCR Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global One Step RT-qPCR Kits Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global One Step RT-qPCR Kits Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Thermo Fisher Scientific Inc. Basic Information And Sales Area

Table 52: Thermo Fisher Scientific Inc.. Products Portfolio

Table 53: QIAGEN Basic Information And Sales Area

Table 54: QIAGEN. Products Portfolio

Table 55: Takara Bio lnc. Basic Information And Sales Area

Table 56: Takara Bio lnc.. Products Portfolio

Table 57: Bio-Rad Laboratories, Inc. Basic Information And Sales Area

Table 58: Bio-Rad Laboratories, Inc.. Products Portfolio

Table 59: Promega Corporation Basic Information And Sales Area

Table 60: Promega Corporation. Products Portfolio

Table 61: New England Biolabs Basic Information And Sales Area

Table 62: New England Biolabs. Products Portfolio

Table 63: Fortis Life Sciences Basic Information And Sales Area

Table 64: Fortis Life Sciences. Products Portfolio

Table 65: Quantabio Basic Information And Sales Area

Table 66: Quantabio. Products Portfolio

Table 67: BIO-HELIX Basic Information And Sales Area

Table 68: BIO-HELIX. Products Portfolio

Table 69: MP Biomedicals Basic Information And Sales Area

Table 70: MP Biomedicals. Products Portfolio

Table 71: Avantor Inc. Basic Information And Sales Area

Table 72: Avantor Inc.. Products Portfolio

Table 73: Intact Genomics, Inc. Basic Information And Sales Area

Table 74: Intact Genomics, Inc.. Products Portfolio

Table 75: Solis BioDyne Basic Information And Sales Area

Table 76: Solis BioDyne. Products Portfolio

Table 77: Applied Biological Materials Inc. Basic Information And Sales Area

Table 78: Applied Biological Materials Inc.. Products Portfolio

Table 79: Merck KGAA Basic Information And Sales Area

Table 80: Merck KGAA. Products Portfolio

Table 81: TIANGEN Biotech(Beijing)Co., Ltd Basic Information And Sales Area

Table 82: TIANGEN Biotech(Beijing)Co., Ltd. Products Portfolio

Table 83: EnzyQuest Basic Information And Sales Area

Table 84: EnzyQuest. Products Portfolio

Table 85: Canvax Basic Information And Sales Area

Table 86: Canvax. Products Portfolio

Table 87: Zymo Research Corporation Basic Information And Sales Area

Table 88: Zymo Research Corporation. Products Portfolio

Table 89: NZYtech Basic Information And Sales Area

Table 90: NZYtech. Products Portfolio

Table 91: Abbexa Basic Information And Sales Area

Table 92: Abbexa. Products Portfolio

Table 93: Boca Scientific Inc. Basic Information And Sales Area

Table 94: Boca Scientific Inc.. Products Portfolio

Table 95: GeneDireX,Inc. Basic Information And Sales Area

Table 96: GeneDireX,Inc.. Products Portfolio

Table 97: Global Market Value (USD Million) (2025-2032) By Type

Table 98: Global Market Share (%) By Type (2032)

Table 99: Global Market Value (USD Million) (2025-2032) By Application

Table 100: Global Market Share (%) By Application (2032)

Table 101: Global Market Volume (K) (2025-2032) By Type

Table 102: Global Market Share (%) By Type (2032)

Table 103: Global Market Volume (K) (2025-2032) By Application

Table 104: Global Market Share (%) By Application (2032)

Table 105: Global One Step RT-qPCR Kits Market Value (USD Million) By Region

Table 106: Global One Step RT-qPCR Kits Market Share (%) By Region (2025-2032)

Table 107: North America Market Value (USD Million) (2025-2032) By Country

Table 108: North America Market Value (USD Million) (2025-2032) By Type

Table 109: North America Market Value (USD Million) (2025-2032) By Application

Table 110: Europe Market Value (USD Million) (2025-2032) By Country

Table 111: Europe Market Value (USD Million) (2025-2032) By Type

Table 112: Europe Market Value (USD Million) (2025-2032) By Application

Table 113: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 114: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 115: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 116: South America Market Value (USD Million) (2025-2032) By Country

Table 117: South America Market Value (USD Million) (2025-2032) By Type

Table 118: South America Market Value (USD Million) (2025-2032) By Application

Table 119: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 120: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 121: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 122: Global One Step RT-qPCR Kits Market Volume (K) By Region

Table 123: Global One Step RT-qPCR Kits Market Share (%) By Region (2025-2032)

Table 124: North America Market Volume (K) (2025-2032) By Country

Table 125: North America Market Volume (K) (2025-2032) By Type

Table 126: North America Market Volume (K) (2025-2032) By Application

Table 127: Europe Market Volume (K) (2025-2032) By Country

Table 128: Europe Market Volume (K) (2025-2032) By Type

Table 129: Europe Market Volume (K) (2025-2032) By Application

Table 130: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 131: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 132: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 133: South America Market Volume (K) (2025-2032) By Country

Table 134: South America Market Volume (K) (2025-2032) By Type

Table 135: South America Market Volume (K) (2025-2032) By Application

Table 136: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 137: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 138: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 139: Research Programs/Design For This Report

Table 140: Key Data Information From Secondary Sources

Table 141: Key Data Information From Primary Sources

FAQs

1. What is the current One Step RT-qPCR Kits market size?

Verified supplier data put the 2023 One Step RT-qPCR Kits market size at roughly USD 1.4 billion, propelled by post-pandemic routine screening and multiplex panel uptake.

2. How fast will the One Step RT-qPCR Kits market grow?

Analysts forecast a 9–11% CAGR through 2030; infectious-disease surveillance, oncology companion diagnostics, and food-safety testing underpin the bullish future outlook.

3. What are the key market drivers?

Rising respiratory outbreaks, shift to single-tube workflows, lyophilized ready mixes, and CLIA-waived point-of-care approvals collectively accelerate kit adoption worldwide.

4. What challenges restrain growth?

Supply-chain shortages of RNase-free plastics, price pressure from Chinese suppliers, and evolving variant-target validation cycles create margin and regulatory hurdles.

5. Which regions lead consumption?

North America holds ~42% share thanks to CDC reference labs; Europe follows with CE-IVDR multiplex panels; APAC is fastest-growing, led by China and India.

6. Who are the top companies?

Thermo Fisher, Qiagen, Bio-Rad, Roche, Takara, Agilent, Merck KGaA, and emerging Chinese rivals such as TianLong and Sansure dominate supplier rankings.

7. Where are future opportunities?

Room-temperature lyophilized beads, CRISPR-enhanced specificity, AI-driven primer libraries, and companion diagnostic co-development contracts represent high-margin white spaces.

8. How is technology reshaping kits?

Digital microfluidic cartridges, 4-color hydrolysis probe chemistry, and integrated RNase inhibitors reduce hands-on time below 15 minutes, enabling airport kiosks and field deployable labs.

9. What does the regulatory landscape look like?

FDA EUA rolling reviews, EU IVDR Class C conformity, and China NMPA batch testing all tighten validation datasets, favoring large players with regulatory affairs teams.

10. Will pricing erode as competition rises?

Yes, average selling prices have fallen 6–8% CAGR; vendors offset this via bundled instruments, reagent rentals, and tiered bulk contracts to lock in molecular diagnostics labs.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

One Step RT-qPCR Kits Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.40 million
Revenue forecast in 2033	3.54 million
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific Inc.; QIAGEN; Takara Bio lnc.; Bio-Rad Laboratories, Inc.; Promega Corporation; New England Biolabs; Fortis Life Sciences; Quantabio; BIO-HELIX; MP Biomedicals; Avantor Inc.; Intact Genomics, Inc.; Solis BioDyne; Applied Biological Materials Inc.; Merck KGAA; TIANGEN Biotech(Beijing)Co., Ltd; EnzyQuest; Canvax; Zymo Research Corporation; NZYtech; Abbexa; Boca Scientific Inc.; GeneDireX,Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options